Cancer Immunology Research

Titel Veröffentlichungsdatum Sprache Zitate
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures2019/05/01English40
Myeloid-Derived Suppressor Cells2017/01/01English23
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival2019/06/01English17
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen2015/04/01English16
NF-κB, an Active Player in Human Cancers2014/09/01English16
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies2015/05/01English14
PD-L1 Expression in Triple-Negative Breast Cancer2014/04/01English13
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation2014/07/01English9
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer2013/12/01English9
Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients2017/10/01English8
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells2016/05/31English8
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC2016/05/01English8
Tumors: Wounds That Do Not Heal—Redux2015/01/01English8
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC2017/05/01English7
Mast Cells: Potential Positive and Negative Roles in Tumor Biology2013/11/01English7
CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful2014/02/01English7
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells2013/07/01English7
Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer2018/12/01English7
PD-1 Blockade Expands Intratumoral Memory T Cells2016/02/29English7
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients2017/04/01English7
In VitroCharacterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, andIn VivoToxicology in Non-Human Primates2014/09/01English7
PD-1 Restrains Radiotherapy-Induced Abscopal Effect2015/06/01English7
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity2014/02/01English7
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues2015/02/01English6
Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types2018/01/01English6
A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer2019/05/01English6
Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy2019/10/01English6
Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy2015/09/01English6
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells2015/10/01English6
T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans2013/07/01English6